Studies have shown that EMP3 supports TGF-β signaling in CD44-high GBM cells [29] and induces an immunosuppressive GBM microenvironment characterized by reduced T cell infiltration and increased amounts of M2 macrophages in animal models [12]. The gene discussed is EMP3; the disease is glioblastoma.